BioMed Central Journal Making an Impact!
Open access journals published by BioMed Central have received impact factors that compare well with equivalent subscription titles. The impact factors, which are calculated by ISI, look at articles published in the journals in the period 2001-2002. The high impact factors, all for journals that are just a few years old, prove that Open Access to research literature achieves impact fast and makes quality articles widely visible.
Arthritis Research & Therapy jumped from 3.44 to 5.03, propelling it to rank second in the rheumatology field in its fifth year of publication. Breast Cancer Research also increased its impact factor, moving from 2.81 to 2.93, placing it on even footing with its direct competitor, Breast Cancer Research & Treatment, which was established more than 20 years ago. Critical Care moved up to 6th in its field, and now has an impact factor of 1.9.
Four journals published by BioMed Central received their first impact factors this year. Respiratory Research (5.53) has taken second place in the respiratory field. Current Controlled Trials in Cardiovascular Medicine has an impact factor of 3.12. BMC Cell Biology (2.61) and BMC Health Services Research (0.67) also entered well.
BioMed Central saw its impact factors go up across the board. BMC Cancer now has an impact factor of 1.7, while BMC Infectious Diseases (1.25) and BMC Public Health (0.93) also saw increases in their impact factors from the 2002 Journal Citation Report.
[SPARC E-NEWS June-July 2004 http://www.arl.org/sparc/core/index.asp?page=g37]
